2022-06-21  12:00:00 AM Chg. - Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
17.1500USD - 100
Turnover: -
-Bid Size: - -Ask Size: - 46.19 mill.USD - -

Business description

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, Indien and the United States in one business segment, Telemedicine services. SHL was founded in 1987 by Yoram Alroy and Elon Shalev.
 

Management board & Supervisory board

CEO
David Arnon
Management board
Amir Hai, Jason Bottiglieri, Bernd Altpeter
Supervisory board
Itamar Offer, Dr. Amir Lerman, Yehoshua Abramovich, Dvora Kimhi, Ido Nouberger, Nir Rotenberg
 

Company data

Name: SHL TeleMedicine Ltd.
Address: 90 Yigal Alon St.,IL-67891 Tel Aviv
Phone: +972-3-5612212
Fax: +972-3-6242414
E-mail: -
Internet: www.shl-telemedicine.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 29.43%
IPO date: -

Investor relations

Name: Martin Meier-Pfister
IR phone: +41-43-2448140
IR Fax: +41-43-244-81-45
IR e-mail: martin.meier-pfister@irfcom.ch

Main Shareholders

Mrs. Cai Mengke and Kun Shen
 
36.42%
Others
 
29.64%
More Provident Funds
 
11.06%
Value Base Group
 
8.35%
Sphera Funds Management Ltd
 
5.00%
Yariv Alroy
 
4.89%
Danbar Finance Ltd.
 
4.64%